Seller record · Telehealth service

WeightRx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The pages refer only to dozens of quality-vetted pharmacies and licensed 503A pharmacies. 2 more criteria also fail; see the table below.

At a glance

WeightRxTelehealth service

5/8criteria passed

Price: Compounded tirzepatide from $83 a month; semaglutide $250 a month
Sells: compounded tirzepatide, compounded semaglutide
FDA letters: None on file

Visit WeightRx See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform selling compounded tirzepatide and semaglutide with the provider review, medication and cold-chain delivery in one monthly price, and listing brand-name Wegovy, Zepbound and Foundayo as coming soon. Care comes from an outside medical group after a free online assessment.

Operating entity Twist G Marketing, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	WeightRx's website; WeightRx's terms; WeightRx's telehealth consent
S2	Prescription gating	PASS	WeightRx's website; WeightRx's terms; WeightRx's refund policy
S3	Pharmacy identification	FAIL	WeightRx's website; WeightRx's terms
S4	Compounding disclosure	PASS	WeightRx's website; WeightRx's notice to consumers page
S5	Analytical documentation	FAIL	WeightRx's website; WeightRx's terms; WeightRx's notice to consumers page
S6	Business address	FAIL	WeightRx's website; WeightRx's terms
S7	Price disclosure	PASS	WeightRx's website; WeightRx's terms; WeightRx's refund policy
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed physician reviews each intake and medical history before any prescription is written, and the terms name MDI Medical Group, PC as the provider.Source: WeightRx's website; WeightRx's terms; WeightRx's telehealth consent.

S2PASSThe steps list a free assessment first, and the terms say charges are authorized before the provider's review and refunded in full if the provider does not approve treatment.Source: WeightRx's website; WeightRx's terms; WeightRx's refund policy.

S3FAILNo filling pharmacy is named. The pages refer only to dozens of quality-vetted pharmacies and licensed 503A pharmacies.Source: WeightRx's website; WeightRx's terms.

S4PASSThe footer of every page states that compounded GLP-1s are not FDA-approved or evaluated for safety, efficacy or quality, and the notice to consumers repeats it. The treatment tiles print the compounded products with a registered-mark symbol.Source: WeightRx's website; WeightRx's notice to consumers page.

S5FAILNo certificate of analysis or lot document is published on the home page, the terms, the notice to consumers or the refund policy.Source: WeightRx's website; WeightRx's terms; WeightRx's notice to consumers page.

S6FAILThe seller prints two different addresses. The footer of every page gives WeightRx, Inc. at 169 Madison Ave, STE 38335, New York, New York 10016, while the terms give Twist G Marketing, LLC at 700 Louisiana Street, Houston, TX 77002.Source: WeightRx's website; WeightRx's terms.

S7PASSCompounded tirzepatide from $83 a month and compounded semaglutide at $250 a month, with the medication, provider review, doctor support and cold-chain delivery included, each price marked with an asterisk the page does not explain. Plans run monthly or for 3, 6 or 12 months, and 6-month and 12-month plans are not refundable.Source: WeightRx's website; WeightRx's terms; WeightRx's refund policy.

S8PASSNo FDA warning letter names WeightRx or Twist G Marketing, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded tirzepatide, compounded semaglutide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit WeightRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.